A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
Stopped The study was terminated for lack of efficacy after an interim analysis was performed
Conditions
- Chronic Spontaneous Urticaria
Interventions
- DRUG: LY3454738
- DRUG: Placebo
Sponsor
Eli Lilly and Company